Integrating immune checkpoint inhibitors and targeted therapies in the treatment of early stage non-small cell lung cancer: a narrative review

অনুরূপ উপাদানগুলি

• Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?—a literature review
  অনুযায়ী: Leone, Gianmarco, অন্যান্য
  প্রকাশিত: (2020)
• Narrative review of molecular pathways of kinase fusions and diagnostic approaches for their detection in non-small cell lung carcinomas
  অনুযায়ী: Matter, Matthias S., অন্যান্য
  প্রকাশিত: (2020)
• Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won
  অনুযায়ী: Tabbò, Fabrizio, অন্যান্য
  প্রকাশিত: (2020)
• Overcoming TKI resistance in fusion-driven NSCLC: new generation inhibitors and rationale for combination strategies
  অনুযায়ী: Russo, Alessandro, অন্যান্য
  প্রকাশিত: (2020)
• Central nervous system metastases and oligoprogression during treatment with tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer: how to treat and when?
  অনুযায়ী: Schoenmaekers, Janna Josephus Anna Oda, অন্যান্য
  প্রকাশিত: (2020)